Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 0 Trial of AMP-1915 for Metabolic Syndrome
NCT02605655Phase 1Completed
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Jun 2014
- Primary completion
- Dec 2014
- Modality
- HM (Herbal Medicine)
01
Overview
Phase 1, randomised, double-blind trial in metabolic syndrome comparing AMP-1915 with Placebo (2 arms). Primary endpoint: Fasting Blood Glucose at 3 months. Started Jun 2014; status: completed.
02
Drugs
AMP-1915
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT02605655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605655.